Abstract
For gastric cancer (GC) control, metastasis and chemoresistance are the major challenges, accompanied with various stresses. Ataxin-2-like (ATXN2L) was discovered as a novel regulator of stress granules, yet its function in cancers remained unknown. Hence, we wanted to explore the functions of ATXN2L to see whether it participates in stress-related cancer malignant activities. Clinical follow-up was performed to see the impact of ATXN2L on GC patient survival. As a result, ATXN2L expression was upregulated in GC tissue and indicated adverse prognosis for overall survival and recurrence. In GC cells, ATXN2L expression was knocked down and functional experiments were performed. ATXN2L promoted GC cell migration and invasion via epithelial to mesenchymal transition, yet no influence on proliferation was detected by ATXN2L interference. When adding the chemotherapeutic agent oxaliplatin to induce stress, silencing ATXN2L sensitized GC cells to oxaliplatin. Interestingly, oxaliplatin was found to in turn promote ATXN2L expression and stress granule assembly. Then, two acquired oxaliplatin-resistant strains were generated by long-term oxaliplatin induction. The oxaliplatin-resistant strains presented with elevated ATXN2L levels, whil...Continue Reading
References
Jul 22, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Anthony D YangLee M Ellis
Dec 21, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Marie PrewettJames R Tonra
Jul 8, 2008·Cellular Signalling·David NonisGeorg Auburger
Aug 23, 2008·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Michèle SabbahChristian Gespach
Sep 9, 2008·Molecular Cell·T S Karin Eisinger-MathasonDeborah A Lannigan
Jan 17, 2009·Cancer Research·Raymond D MengGary K Schwartz
Dec 15, 2010·Oncogene·I MartinsG Kroemer
Apr 18, 2012·Oncogene·H X ZhengB Jiang
Dec 5, 2012·PloS One·Christian KaehlerSylvia Krobitsch
Mar 5, 2013·International Journal of Cancer. Journal International Du Cancer·Lin WangWangjun Liao
Apr 15, 2014·Nucleic Acids Research·Christian KaehlerSylvia Krobitsch
Jul 22, 2014·Oncogene·L LinW Liao
Oct 17, 2014·British Journal of Cancer·X WangY Ba
Dec 9, 2014·Biochimica Et Biophysica Acta·Paul AndersonPavel Ivanov
Apr 25, 2015·Oncotarget·Liang ZhaoWangjun Liao
Jan 11, 2017·Molecular Cancer Therapeutics·Peilong LiChuanxin Wang
Jul 12, 2017·Oncogene·H-Q JuR-H Xu
Jul 15, 2017·Cell Death and Differentiation·Roberta CianfroccaAnna Bagnato
Oct 11, 2017·Cancer Letters·Junli MaHong Shen
Dec 22, 2017·Oncotarget·Ioannis PanagopoulosSverre Heim
Dec 22, 2017·Oncotarget·Yuan QinCheng Yang
Citations
Oct 30, 2019·Antioxidants·Eun-Kyung KimHo Hee Jang
Sep 19, 2019·Cancers·Yoojung KwonDooil Jeoung
Jul 24, 2020·International Journal of Molecular Sciences·Jana KeySuzana Gispert
Mar 17, 2020·Frontiers in Pharmacology·Hui XieLuo Gu
May 7, 2020·Genes·Chang-In MoonAngela C Hirbe
Oct 2, 2019·European Journal of Pharmacology·Sepideh HamzehlouSeyed H Ghaffari
Jul 3, 2019·Neurological Research and Practice·Isabel Lastres-BeckerGeorg Auburger
Jan 31, 2021·Pharmaceuticals·Susie L Brown, Samantha Kendrick
Mar 30, 2021·Frontiers in Endocrinology·Weiwei Liang, Fangfang Sun
Jun 13, 2021·Cell Death Discovery·Yi DaiLiming Tang
Jul 29, 2021·BMC Genomics·Ruoting LinTianfang Wang
Jul 31, 2021·Oncogene·Ziyang LiuJiafu Ji
Oct 5, 2021·Frontiers in Cell and Developmental Biology·Mohammad Reza AsadiMaryam Rezazadeh